NCT05598151 - Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors | Biotech Hunter

Enrollment

170

Participants

Timeline

Start Date

January 11, 2023

Primary Completion Date

January 31, 2028

Study Completion Date

June 30, 2028

Conditions

Advanced or Metastatic Solid Tumors

Interventions

DRUG

HM97662

To evaluate the safety, tolerability, preliminary anti-tumor efficacy, PK and PD of HM97662 in solid tumors

Trial Locations (10)

RECRUITING

Cancer Research SA, Adelaide

RECRUITING

Grampians Health, Ballarat

RECRUITING

Monash Medical Centre, Clayton

RECRUITING

Peninsula and Southeast Oncology, Frankston

NOT_YET_RECRUITING

National Cancer Center, Goyang-si

RECRUITING

Asan Medical Center, Seoul

NOT_YET_RECRUITING

Samsung Medical Center, Seoul

RECRUITING

Seoul National University Bundang Hospital, Seoul

RECRUITING

Seoul National University Hospital, Seoul

RECRUITING

The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul